Loading clinical trials...
Loading clinical trials...
A Phase II, Multicenter, Single-Arm Study of Sonrotoclax, Zanubrutinib and Rituximab in Previously Untreated Patients With Follicular Lymphoma (FLOURISH)
Conditions
Interventions
Sotoclax in combination with zanubrutinib and rituximab regimen
Locations
1
China
Sun Yat-sen Universitiy Cancer Center
Guangzhou, Guangdong, China
Start Date
September 1, 2026
Primary Completion Date
March 30, 2028
Completion Date
September 30, 2029
Last Updated
April 24, 2026
NCT06191744
NCT06043011
NCT04488354
NCT05888493
NCT07360288
NCT02362035
Lead Sponsor
Sun Yat-sen University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions